Trials / Completed
CompletedNCT05608018
Preventing Distracted Driving Phase II
A Novel Distracted Driving Prevention Technology Phase II
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 500 (actual)
- Sponsor
- Minnesota HealthSolutions · Industry
- Sex
- All
- Age
- 16 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to determine the efficacy of a smartphone app in reducing mobile phone use while driving among teens and parents. Prior to sending a message, the smartphone app informs a potential message sender that the recipient is driving.
Detailed description
The primary objective of this study is to determine whether the app reduces (1) smartphone communication sent from parent to teen while the teen is driving; and (2) smartphone communication sent from teen while the teen is driving. The secondary objectives are to: Determine whether the app reduces smartphone communication sent from teen to parent while parent is driving; Evaluate the acceptability of the app among parents and teens; and determine the relationship between individual differences (demographics, typical smartphone use, driving history, risk perception) and the app's efficacy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Intervention Bluetooth | Participants will receive a Bluetooth device to use for the duration of the study, and will use the app with all features turned on. |
| OTHER | Intervention non-Bluetooth | Participants will not receive a Bluetooth device, and will use the app with all features turned on. |
| OTHER | Control Bluetooth | Participants will receive a Bluetooth device to use for the duration of the study, and will use the app with some features turned off. |
| OTHER | Control non-Bluetooth | Participants will not receive a Bluetooth device, and will use the app with some features turned off. |
Timeline
- Start date
- 2023-06-26
- Primary completion
- 2024-07-23
- Completion
- 2024-07-23
- First posted
- 2022-11-07
- Last updated
- 2025-05-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05608018. Inclusion in this directory is not an endorsement.